AQR Capital Management
JBIO

AQR Capital Management’s Jade Biosciences JBIO Stock Holding History

AQR Capital Management’s Portfolio JBIO Stock Details JBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$296K Buy
+13,311
New +$278K ﹤0.01% 3628
2025
Q2 		– Sell
-618
Closed -$54.3K – 3298
2025
Q1 		$54.3K Buy
618
+79
+15% +$6.94K ﹤0.01% 3076
2024
Q4 		$50K Sell
539
-757
-58% -$65.2K ﹤0.01% 2806
2024
Q3 		$94.8K Buy
+1,296
New +$83.6K ﹤0.01% 2659

Other funds holding JBIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

AQR Capital Management's JBIO Position: Q2 2026 in Review

AQR Capital Management opened a new position in Jade Biosciences (JBIO) in Q2 2026: 13,311 shares worth $296K. The stake represents ﹤0.01% of the portfolio and ranks #3628 among its holdings. This is a return to the name: AQR Capital Management previously reported a position in JBIO as recently as Q1 2025.

AQR Capital Management first reported a position in JBIO in Q3 2024 and has held it in 4 quarters since. 153 funds tracked by Wall St. Rank hold JBIO as of Q2 2026.

  • AQR Capital Management held 13,311 shares of Jade Biosciences worth $296K as of Q2 2026.
  • Jade Biosciences was a new AQR Capital Management position in Q2 2026.
  • Jade Biosciences made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #3628 holding.
  • AQR Capital Management first reported a position in Jade Biosciences in Q3 2024 and has held it in 4 quarters since.
  • 153 funds tracked by Wall St. Rank held Jade Biosciences as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.